299 related articles for article (PubMed ID: 23903002)
1. Octapod iron oxide nanoparticles as high-performance T₂ contrast agents for magnetic resonance imaging.
Zhao Z; Zhou Z; Bao J; Wang Z; Hu J; Chi X; Ni K; Wang R; Chen X; Chen Z; Gao J
Nat Commun; 2013; 4():2266. PubMed ID: 23903002
[TBL] [Abstract][Full Text] [Related]
2. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
[TBL] [Abstract][Full Text] [Related]
3. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
[TBL] [Abstract][Full Text] [Related]
4. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
[TBL] [Abstract][Full Text] [Related]
5. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents.
Lartigue L; Hugounenq P; Alloyeau D; Clarke SP; Lévy M; Bacri JC; Bazzi R; Brougham DF; Wilhelm C; Gazeau F
ACS Nano; 2012 Dec; 6(12):10935-49. PubMed ID: 23167525
[TBL] [Abstract][Full Text] [Related]
6. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
7. Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents.
Maity D; Zoppellaro G; Sedenkova V; Tucek J; Safarova K; Polakova K; Tomankova K; Diwoky C; Stollberger R; Machala L; Zboril R
Chem Commun (Camb); 2012 Dec; 48(93):11398-400. PubMed ID: 23066527
[TBL] [Abstract][Full Text] [Related]
8. Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles.
Mejías R; Pérez-Yagüe S; Roca AG; Pérez N; Villanueva A; Cañete M; Mañes S; Ruiz-Cabello J; Benito M; Labarta A; Batlle X; Veintemillas-Verdaguer S; Morales MP; Barber DF; Serna CJ
Nanomedicine (Lond); 2010 Apr; 5(3):397-408. PubMed ID: 20394533
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
10. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
Tähkä S; Laiho A; Kostiainen MA
Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
[TBL] [Abstract][Full Text] [Related]
11. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
12. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
13. HER2/neu antibody conjugated poly(amino acid)-coated iron oxide nanoparticles for breast cancer MR imaging.
Yang HM; Park CW; Woo MA; Kim MI; Jo YM; Park HG; Kim JD
Biomacromolecules; 2010 Nov; 11(11):2866-72. PubMed ID: 20932000
[TBL] [Abstract][Full Text] [Related]
14. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
Lee N; Hyeon T
Chem Soc Rev; 2012 Apr; 41(7):2575-89. PubMed ID: 22138852
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
[TBL] [Abstract][Full Text] [Related]
16. Iron-oxide-based twin nanoplates with strong T
Wei R; Zhou T; Sun C; Lin H; Yang L; Ren BW; Chen Z; Gao J
Nanoscale; 2018 Oct; 10(38):18398-18406. PubMed ID: 30256373
[TBL] [Abstract][Full Text] [Related]
17. Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging.
Jeon SL; Chae MK; Jang EJ; Lee C
Chemistry; 2013 Mar; 19(13):4217-22. PubMed ID: 23345158
[TBL] [Abstract][Full Text] [Related]
18. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
19. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
20. Highly magnetic iron carbide nanoparticles as effective T(2) contrast agents.
Huang G; Hu J; Zhang H; Zhou Z; Chi X; Gao J
Nanoscale; 2014 Jan; 6(2):726-30. PubMed ID: 24287667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
